Jiangsu Hengrui Medicine
600276.SS
$5.76
Share price
-1.58%
Change (1 day)
-18.64%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Earnings for Jiangsu Hengrui Medicine (600276.SS)
Earnings in 2023 (TTM): $0.60 B
According to Jiangsu Hengrui Medicine 's latest financial reports the company's current earnings (TTM) are $0.60 B. In 2022 the company made an earning of $0.59 B a decrease over its 2021 earnings that were of $0.68 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Jiangsu Hengrui Medicine from 2002 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $0.60 B | 1.7% |
| 2022 | $0.59 B | -13.74% |
| 2021 | $0.68 B | -34.14% |
| 2020 | $1.04 B | 15.95% |
| 2019 | $0.89 B | 33.03% |
| 2018 | $0.67 B | 20.89% |
| 2017 | $0.55 B | 23.89% |
| 2016 | $0.45 B | 11.2% |
| 2015 | $0.40 B | 39.5% |
| 2014 | $0.29 B | 20.61% |
| 2013 | $0.24 B | 11.46% |
| 2012 | $0.21 B | 29.7% |
| 2011 | $0.16 B | 31.16% |
| 2010 | $0.12 B | 27.92% |
| 2009 | $99.45 M | 5.8% |
| 2008 | $93.99 M | 79.95% |
| 2007 | $52.23 M | 32.89% |
| 2006 | $39.3 M | 38.19% |
| 2005 | $28.44 M | 21.56% |
| 2004 | $23.4 M | 13.95% |
| 2003 | $20.53 M | 38.06% |
| 2002 | $14.87 M |